What is Quantum-Si incorporated?
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
QSIAW · Verdict
Moderate reward · elevated risk
QSIAW stands out on balance sheet and valuation, but watch the volatility signal.
Based on 88% data coverage
QSIAW · Verdict
Current ratio 11.99
Above average
Weak vs peers
-3021% free-cash-flow margin
-3303% net margin · -52% ROE
Model-based scoring. For information only — not financial advice.
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. The company is listed on the NASDAQ in USA, with a market capitalisation of 1.44B.
The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.